Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-06-16 Sale |
2022-06-21 4:37 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer |
1,768 | $10.75 | $19,006 | 76,884 (Direct) |
View |
| 2022-06-16 Sale |
2022-06-21 4:36 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks |
1,298 | $10.75 | $13,954 | 36,661 (Direct) |
View |
| 2022-06-16 Sale |
2022-06-21 4:35 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer |
1,311 | $10.75 | $14,093 | 49,521 (Direct) |
View |
| 2022-06-16 Sale |
2022-06-21 4:35 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer |
1,768 | $10.75 | $19,006 | 46,080 (Direct) |
View |
| 2022-06-16 Sale |
2022-06-21 4:34 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
1,768 | $10.75 | $19,006 | 367,553 (Indirect Direct) |
View |
| 2022-04-29 Purchase |
2022-04-29 4:31 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Brightstar Associates LLC 10% Owner |
1,478,978 | $10 | $14,789,780 | 21,441,178 (Direct) |
View |
| 2022-02-16 Sale |
2022-02-18 5:01 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
1,366 | $9.05 | $12,362 | 369,321 (Indirect Direct) |
View |
| 2022-02-16 Sale |
2022-02-18 5:01 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer |
1,146 | $9.05 | $10,371 | 48,668 (Direct) |
View |
| 2022-02-16 Sale |
2022-02-18 5:01 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer |
984 | $9.05 | $8,905 | 76,790 (Direct) |
View |
| 2022-02-16 Sale |
2022-02-18 5:01 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer |
1,368 | $9.05 | $12,380 | 47,848 (Direct) |
View |
| 2022-02-16 Sale |
2022-02-18 5:00 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks |
1,146 | $9.05 | $10,371 | 37,959 (Direct) |
View |
| 2021-10-04 Sale |
2021-10-06 4:00 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer |
2,659 | $33.17 | $88,199 | 46,029 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-23 Option Award |
2022-06-24 4:05 pm |
N/A 2032-06-22 |
Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director |
18,500 | $0 | 18,500 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-24 4:05 pm |
N/A 2032-06-22 |
Deciphera Pharmaceuticals Inc. | DCPH | Squarer Ron Director |
18,500 | $0 | 18,500 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-24 4:05 pm |
N/A 2032-06-22 |
Deciphera Pharmaceuticals Inc. | DCPH | Martin John Richard Director |
18,500 | $0 | 18,500 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-24 4:05 pm |
N/A 2032-06-22 |
Deciphera Pharmaceuticals Inc. | DCPH | Kelley Susan L. Director |
18,500 | $0 | 18,500 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-24 4:05 pm |
N/A 2032-06-22 |
Deciphera Pharmaceuticals Inc. | DCPH | Benz Edward J. JR Director |
18,500 | $0 | 18,500 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-24 4:05 pm |
N/A 2032-06-22 |
Deciphera Pharmaceuticals Inc. | DCPH | Allen Patricia L Director |
18,500 | $0 | 18,500 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-24 4:05 pm |
N/A 2032-06-22 |
Deciphera Pharmaceuticals Inc. | DCPH | Friedman Franklin Stuart Director |
18,500 | $0 | 18,500 (Direct) |
View |
| 2022-03-21 Tax Withholding |
2022-03-23 4:15 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. President and CEO |
3,150 | $9.11 | 37,545 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-20 5:01 pm |
N/A 2032-01-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director |
9,570 | $5.22 | 9,570 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-20 5:01 pm |
N/A 2032-01-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Walsh Dennis Leo Director |
9,570 | $5.22 | 9,570 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-20 5:01 pm |
N/A 2032-01-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Kelley Susan L. Director |
9,570 | $5.22 | 9,570 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-20 5:01 pm |
N/A 2032-01-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Squarer Ron Director |
9,570 | $5.22 | 9,570 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-20 5:00 pm |
N/A 2032-01-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Allen Patricia L Director |
9,570 | $5.22 | 9,570 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-20 5:00 pm |
N/A 2032-01-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer |
102,500 | $0 | 131,216 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-20 5:00 pm |
N/A 2032-01-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Friedman Franklin Stuart Director |
9,570 | $5.22 | 9,570 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-20 5:00 pm |
N/A 2032-01-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer |
68,334 | $0 | 104,481 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-20 5:00 pm |
N/A 2032-01-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer |
102,500 | $0 | 159,774 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-20 5:00 pm |
N/A 2032-01-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks |
68,334 | $0 | 93,772 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-20 5:00 pm |
N/A 2032-01-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
102,500 | $0 | 452,687 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-20 5:00 pm |
N/A 2032-01-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. President and CEO |
415,000 | $0 | 415,000 (Direct) |
View |
| 2021-12-15 Option Award |
2021-12-17 4:10 pm |
N/A 2031-12-14 |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer |
93,365 | $0 | 110,981 (Direct) |
View |
| 2021-12-15 Option Award |
2021-12-17 4:10 pm |
N/A 2031-12-14 |
Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks |
71,271 | $0 | 88,409 (Direct) |
View |
| 2021-12-15 Option Award |
2021-12-17 4:10 pm |
N/A 2031-12-14 |
Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. President and CEO |
270,357 | $0 | 311,052 (Direct) |
View |
| 2021-12-15 Option Award |
2021-12-17 4:05 pm |
N/A 2031-12-14 |
Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer |
93,365 | $0 | 139,539 (Direct) |
View |
| 2021-12-15 Option Award |
2021-12-17 4:00 pm |
N/A 2031-12-14 |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
93,365 | $0 | 432,452 (Direct) |
View |
| 2021-12-15 Option Award |
2021-12-17 4:00 pm |
N/A 2031-12-14 |
Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer |
71,271 | $0 | 99,118 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-25 4:00 pm |
N/A 2031-06-22 |
Deciphera Pharmaceuticals Inc. | DCPH | Walsh Dennis Leo Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-25 4:00 pm |
N/A 2031-06-22 |
Deciphera Pharmaceuticals Inc. | DCPH | Friedman Franklin Stuart Director |
12,000 | $0 | 12,000 (Direct) |
View |